 |
Oncology Phase II program |
|
| |
3 studies |
| |
450 patients |
| |
17 countries |
| |
2-4 year program |
| |
Clinical Trial submissions in all countries |
| |
Clinical Monitoring |
| |
Clinical Management |
| |
Logistics support (warehouses, import/export licences, etc.) |
| |
|
| |
QED has been chosen because the Sponsor was looking for a pan-European coverage, an attractive price and "above the average" experience and dedication. |
| |
|
| |
*Please select the icon to download case study pdf |
 |
|
| |
|
